Dr. Naseer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
US Food and Drug Administration
10903 New Hampshire ave
Silver Spring, MD 20903- Is this information wrong?
Education & Training
- MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 2006 - 2008
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 2003 - 2006
- Philadelphia College of Osteopathic MedicineClass of 2003
Certifications & Licensure
- MD State License 2010 - 2025
- DC State License 2006 - 2010
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 7 citationsCefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy.Xiaohui Wei, Shabnam Naseer, Edward A Weinstein, Dmitri Iarikov, Sumathi Nambiar, Kellie S Reynolds, Seong H Jang> ;Clinical Pharmacology and Therapeutics. 2022 Nov 1
- 29 citationsUS Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®).Shabnam Naseer, Edward A. Weinstein, Daniel B. Rubin, Kalavati Suvarna, Xiaohui Wei, Karen Higgins, Avery Goodwin, Seong H. Jang, Dmitri Iarikov, John Farley, Sumathi ...> ;Clinical Infectious Diseases. 2021 Jun 15
Professional Memberships
- Member
- Member
Hospital Affiliations
- University of Maryland Upper Chesapeake Medical CenterBel Air, Maryland
- University of Maryland Harford Memorial HospitalHavre De Grace, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: